Classification of breast tissue density by optical transillumination spectroscopy: Optical and physiological effects governing predictive value

Medical Physics

Volumn 31, Issue 6, 2004, Pages 1398-1414

  Blyschak, Kristina ^a   Simick, Michelle ^b   Jong, Roberta ^c   Lilge, Lothar ^a,d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer risk; Breast tissue density; Optical transillumination spectroscopy; Principal components analysis

Indexed keywords

DISEASES; SPECTRUM ANALYSIS; TISSUE; TRANSILLUMINATION;

BREAST CANCER RISK; BREAST TISSUES; CLASSIFICATION OF BREAST TISSUES; MONITORING TECHNIQUES; NONIONIZING RADIATION; PHYSIOLOGICAL EFFECTS; PRINCIPAL COMPONENTS ANALYSIS; THREE-DIMENSIONAL CLUSTERS;

RISK ASSESSMENT;

ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER RISK; DENSITY; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OPTICAL TRANSILLUMINATION SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SPECTROSCOPY; TISSUE;

EID: 3042594468     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1738191     Document Type: Article

References (34)

1. G. S. Dite, M. A. Jenkins, M. C. Southey, J. S. Hocking, G. G. Giles, M. R. McCredie, D. J. Venter, and J. L. Hopper, "Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations," J. Natl. Cancer Inst. 95, 448-457 (2003).
2. National Cancer Institute of Canada, Canadian Cancer Statistics 2001, Toronto, Canada, 2001.
3. L. E. Janocko, K. A. Brown, C. A. Smith, L. P. Gu, A. A. Pollice, S. G. Singh, T. Julian, N. Wolmark, L. Sweeney, J. F. Silverman, and S. S. Shackney, "Distinctive patterns of Her-2/Neu, c-myc and Cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers," Cytometry 46, 136-149 (2001).
4. G. Rollins, "Tamoxifen and raloxifene may benefit women at high risk for breast cancer," Rep. Med. Geidel Outcomes Res. 13, 1-2 (2002).
5. E. Remmel and F. Harder, "Prophylactic mastectomy-Evaluation and treatment of high risk patients," Swiss Surg. 8, 45-52 (2002).
6. N. F. Boyd, G. A. Lockwood, J. Byng, D. L. Tritchler, and M. Yaffe, "Mammographic densities and breast cancer risk," Cancer Epidemiol. Biomarkers Prev. 7, 1133-1144 (1998).
7. N. F. Boyd, J. W. Byng, R. A. Jong, E. K. Fishell, L. E. Little, A. B. Miller, G. A. Lockwood, D. L. Tritchler, and M. J. Yaffe, "Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study," J. Natl. Cancer Inst. 87, 670-675 (1995).
8. J. N. Wolfe, "Breast patterns as an index of risk for developing breast cancer," Am. J. Roentgenol. 126, 1130-1137 (1976).
9. J. N. Wolfe, "Risk of breast cancer development determined by mammographic parenchymal pattern," Cancer 37, 2486-2492 (1976).
10. N. F. Boyd, B. O'Sullivan, J. E. Campbell, E. Fishell, I. Simor, G. Cooke, and T. Germanson, "Mammographic signs as risk factors for breast cancer," Br. J. Cancer 45, 185-193 (1982).
11. J. Brisson, F. Merletti, and N. L. Sadowsky, "Mammographic features of the breast and breast cancer risk," Am. J. Epidemiol. 115, 428-437 (1982).
12. J. N. Wolfe, A. F. Saftlas, and M. Salane, "Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study," Am. J. Roentgenol. 148, 1087-1092 (1987).
13. A. F. Saftlas, R. N. Hoover, L. A. Brinton, M. Szklo, D. R. Olson, M. Salane, and J. N. Wolfe, "Mammographic densities and risk of breast cancer," Cancer 67, 2833-2838 (1991).
14. J. Whitehead, T. Carlile, K. J. Kopecky, D. J. Thompson, F. I. Gilbert, Jr., A. J. Present, B. A. Threatt, P. Krook, and E. Hadaway, "The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors and the incidence of breast cancer," Am. J. Epidemiol. 122, 94-1006 (1985).
15. E. Paci, S. Duffy, and M. Rosseli di Truco, "Mammographic screening: from the scientific evidence to practice," in The Oxford Textbook of Oncology (Oxford University Press, New York, 2000).
16. H. Heusmann, J. Kolzer, J. Otto, R. Plus, T. Friedrich, S. Heywang-Kobrunner, and W. Zinth, "Spectral transillumination of female breasts and breast-like material," Proc. SPIE 2326, 370-382 (2001).
17. V. Quaresima, S. J. Matcher, and M. Ferrari, "Identification and quantification of intrinsic optical contrast for near-infrared mammography," Photochem. Photobiol. 67, 4-14 (1998).
18. R. L. Egan and P. D. Dolan, "Optical spectroscopy. Pre-mammography marker," Acta Radiol. 29, 497-503 (1988).
19. M. Simick, "Near infrared transillumination spectroscopy of breast tissue for correlation with mammographic density," Masters thesis, Department of Medical Biophysics, University of Toronto, 2002.
20. International Electrotechnical Commission, Group Safety of Laser Products Part I: Equipment classification, requirements and user's guide. IEC, Geneva Switzerland, 1993.
21. V. G. Peters, D. R. Wyman, M. S. Patterson, and G. L. Frank, "Optical properties of normal and diseased human breast tissues in the visible and near infrared," Phys. Med. Biol. 35, 1317-1334 (1990).
22. R. A. Weersink, L. D. Marret, and L. Lilge, "Validation of self-reported skin color via principal component analysis of diffuse reflectance spectra of the skin," Proc. Soc. Photo-Opt. Instrum. Eng. 3917, 232-237 (2000).
23. B. M. Wise, PLS Toolbox Tutorial: Matlab Version 6, Eigenvector Research Inc., 2000.
24. Optical-Thermal Response of Laser-Irradiated Tissue, edited by A. J. Welch and M. J. C. van Gemert (Plenum, New York, 1995).
25. N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, "Noninvasive functional optical spectroscopy of human breast tissue," Proc. Natl. Acad. Sci. U.S.A. 98, 4420-4425 (2001).
26. R. Cubeddu, G. M. Danesini, F. Messina, A. Pifferi, L. Spinelli, P. Taroni, and A. Torricelli, "Four wavelength time resolved optical mammograph," Proc. Soc. Photo-Opt. Instrum. Eng. 4955, 203-210 (2003).
27. A. E. Cerussi, A. J. Berger, F. Bevilacqua, N. Shah, D. Jakubowski, J. Butler, R. F. Holocombe, and B. Tromberg, "Sources of absorption and scattering contrast for near-infrared optical tomography," Acad. Radiol. 8, 211-218 (2001).
28. S. J. Graham, M. J. Bronskill, J. W. Byng, M. J. Yaffe, and N. F. Boyd, "Quantitative correlation of breast tissue parameters using magnetic resonance and x-ray mammography," Br. J. Cancer 73, 162-168 (1996).
29. A. I. Mushlin, R. W. Kouides, and D. E. Shapiro, "Estimating the accuracy of screening mammography: A meta-analysis," Am. J. Prev. Med. 14, 143-153 (1998).
30. I. J. Bigio, S. G. Brown, G. Briggs, C. Kelly, S. Lakhani, D. Pickard, P. M. Ripley, I. G. Rose, and C. Saunders, "Diagnosis of breast cancer using elastic scattering spectroscopy: preliminary clinical results," J. Biomed. Opt. 5, 221-228 (2000).
31. C. Byrne, C. Schairer, J. Wolfe, N. Parekh, M. Salane, L. A. Brinton, R. Hoover, and R. Haile, "Mammographic features and breast cancer risk: effects with time, age and menopause status," J. Natl. Cancer Inst. 97, 1622-1629 (1995).
32. M. C. Pike, M. D. Krailo, B. E. Henderson, J. T. Casagrande, and D. G. Hoel, "Hormonal risk factors, breast tissue age and the age-incidence of breast cancer," Nature (London) 303, 767-770 (1983).
33. D. J. Hunter and W. C. Willett, "Diet, body size and breast cancer," Epidemiol. Rev. 15, 110-132 (1993).
34. C. Stromper, J. D'Souza, A. DiNitto, and A. Arrendo, "Analysis of parenchymal density on mammograms in 1353 women 25-79 years old," Am. J. Roentgenol. 167, 1261-1265 (1996).